Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Abstract Potential G protein-coupled receptor kinase (GRK) and protein kinase A (PKA) mediation of homologous desensitization of corticotropin-releasing factor type 1 (CRF 1 ) receptors was investigated in human retinoblastoma Y-79 cells. Inhibition of PKA activity by PKI 5–22 or H-89 failed to attenuate homologous desensitization of CRF 1 receptors, and direct activation of PKA by forskolin or dibutyryl cAMP failed to desensitize CRF-induced cAMP accumulation. However, treatment of permeabilized Y-79 cells with heparin, a nonselective GRK inhibitor, reduced homologous desensitization of CRF 1 receptors by ∼35%. Furthermore, Y-79 cell uptake of a GRK3 antisense oligonucleotide (ODN), but not of a random or mismatched ODN, reduced GRK3 mRNA expression by ∼50% without altering GRK2 mRNA expression and inhibited homologous desensitization of CRF 1 receptors by ∼55%. Finally, Y-79 cells transfected with a GRK3 antisense cDNA construct exhibited an ∼50% reduction in GRK3 protein expression and an ∼65% reduction in homologous desensitization of CRF 1 receptors. We conclude that GRK3 contributes importantly to the homologous desensitization of CRF 1 receptors in Y-79 cells, a brain-derived cell line. antisense G protein-coupled receptor kinase corticotropin-releasing factor type 1 receptor regulation homologous and heterologous desensitization of the CRF 1 receptor Footnotes R. L. Hauger received support from a Veterans Affairs Merit Review grant; the VA VISN 22 Mental Illness Research, Education and Clinical Center (MIRECC); and the National Institute of Mental Health Mental Health Clinical Research Center (PHS MH-20914–14). A portion of this research received financial support from the Max Planck Institute for Experimental Medicine, Department of Molecular Neuroendocrinology (Director: Dr. Joachim Spiess), Goettingen, Germany. Address for reprint requests and other correspondence: R. L. Hauger, VA Medical Center and Dept. of Psychiatry, Univ. of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603 (E-mail: rhauger@ucsd.edu ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Copyright © 2001 the American Physiological Society
AJP - Regulatory, Integrative and Comparative Physiology – The American Physiological Society
Published: Apr 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.